Prime Capital Investment Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Buy
7,595
+63
+0.8% +$13.1K 0.02% 394
2026
Q1
$1.59M Buy
7,532
+675
+10% +$145K 0.02% 399
2025
Q4
$1.41M Buy
6,857
+141
+2% +$26.5K 0.02% 423
2025
Q3
$1.05M Sell
6,716
-676
-9% -$104K 0.01% 476
2025
Q2
$1.24M Buy
7,392
+1,150
+18% +$171K 0.02% 430
2025
Q1
$860K Buy
6,242
+1,019
+20% +$130K 0.01% 538
2024
Q4
$618K Buy
5,223
+605
+13% +$70.6K 0.01% 527
2024
Q3
$510K Buy
4,618
+472
+11% +$49.3K 0.01% 584
2024
Q2
$408K Buy
4,146
+594
+17% +$60.5K 0.01% 633
2024
Q1
$397K Buy
3,552
+641
+22% +$69.2K 0.01% 690
2023
Q4
$293K Buy
+2,911
New +$289K ﹤0.01% 744
2019
Q1
Sell
-16
Closed -$1K 323
2018
Q4
$1K Buy
+16
New +$834 ﹤0.01% 338

Other funds holding CAH

Prime Capital Investment Advisors's CAH Position: Q2 2026 in Review

Prime Capital Investment Advisors increased its Cardinal Health (CAH) stake by 0.84% in Q2 2026, buying an estimated $13.1K and bringing the position to 7,595 shares worth $1.8M. The position accounts for 0.02% of the portfolio, ranked #394.

Prime Capital Investment Advisors first reported a position in CAH in Q4 2018 and has held it in 12 quarters since. 1,109 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Prime Capital Investment Advisors held 7,595 shares of Cardinal Health worth $1.8M as of Q2 2026.
  • Prime Capital Investment Advisors bought 63 Cardinal Health shares in Q2 2026, an estimated $13.1K.
  • Cardinal Health made up 0.02% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #394 holding.
  • Prime Capital Investment Advisors first reported a position in Cardinal Health in Q4 2018 and has held it in 12 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.